LamPORE Mobile Laboratories Purchase
A Contract Award Notice
by DEPARTMENT OF HEALTH AND SOCIAL CARE
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- not specified
- Value
- £4M
- Sector
- TRANSPORT
- Published
- 08 Jan 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
London
2 buyers
1 supplier
- Oxford Nanopore Technologies Oxford
Description
Mobile Laboratories (no cab) fitted out with LamPORE equipment
Award Detail
1 | Oxford Nanopore Technologies (Oxford)
|
Award Criteria
PRICE | _ |
CPV Codes
- 34223330 - Mobile units on trailers
Indicators
- Award on basis of price.
Legal Justification
The procurement relied on Regulation 32 of the PCR 2015 and award using the negotiated procedure without a prior call for competition, because : One possible provider (Reg 32(2)(b)(ii) and (iii) The supplies can only be provided by the particular supplier in the case of Oxford Nanopore because: competition is absent for technical reasons as a result of the Nanopore Technology Solution only being provided by this supplier. and there is also: no reasonable alternative or substitute for the supplier in the case of Oxford Nanopore because the technology determines the build requirements and needs to be an integral part of the process; and the assessment of lack of competition is not as a result of the parameters of the relevant requirements being narrowed to favour the award to a particular supplier only that that that supplier’s technology is being tested. Extreme urgency (Reg 32(2)(c)) The requirement is: extremely urgent and strictly necessary because the purchase of LamPORE Mobile Laboratories is a critical component of Mass Testing, providing laboratory facility to outbreak response areas, remote locations where laboratory capacity is not available and where an urgent response is required. Mobile lab deployment will reduce transit time for samples to travel to a static lab location therefore reducing test turnaround time. Provision of LamPORE Mobile Laboratories will provide agile and adaptable choices for policy makers enabling decision and policy choices to support national and local responses; and the events leading to the extreme urgency were not foreseeable by us due to focus on priority given to static labs; and the time limits to carry out one of the competitive procedures under the PCR 2015 cannot be complied with because the need is imminent.
Reference
- FTS 000378-2021